We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
-5.97%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$522M
AUM Growth
-$108M
Cap. Flow
-$65.4M
Cap. Flow %
-12.54%
Top 10 Hldgs %
27.83%
Holding
119
New
12
Increased
37
Reduced
37
Closed
11

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$19.3M
2
MDT icon
Medtronic
MDT
+$16.9M
3
PFE icon
Pfizer
PFE
+$10.7M
4
ELV icon
Elevance Health
ELV
+$7.8M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$6.07M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$26.6M
2
CELG
Celgene Corp
CELG
+$10.4M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$8.57M
4
UNH icon
UnitedHealth
UNH
+$8.21M
5
MRK icon
Merck
MRK
+$7.97M

Sector Composition

Rank Sector Weight
1 Healthcare 94.79%
2 Financials 1.61%
3 Technology 0.16%
4 Energy 0.11%
5 Consumer Discretionary 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAL icon
101
Halliburton
HAL
$26.6B
$267K 0.05%
4,931
+700
+17% +$34.9K
MRTX
102
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$238K 0.05%
50,000
– –
BUD icon
103
AB InBev
BUD
$165B
$230K 0.04%
+2,180
New +$244K
OREX
104
DELISTED
Orexigen Therapeutics, Inc.
OREX
$209K 0.04%
120,000
– –
CAT icon
105
Caterpillar
CAT
$387B
$144K 0.03%
1,548
-630
-29% -$57.1K
ANTH
106
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$130K 0.02%
25,000
-12,500
-33% -$216K
ISEE
107
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$116K 0.02%
+23,920
New +$710K
MTEM
108
DELISTED
Molecular Templates, Inc.
MTEM
$89K 0.02%
1,221
– –
BHC icon
109
Bausch Health
BHC
$2.34B
– –
-50,000
Closed -$1.23M
COO icon
110
Cooper Companies
COO
$14.5B
– –
-80,000
Closed -$3.59M
JNJ icon
111
Johnson & Johnson
JNJ
$625B
– –
-15,000
Closed -$1.77M
MCK icon
112
McKesson
MCK
$101B
– –
-25,000
Closed -$4.17M
RAD
113
DELISTED
Rite Aid Corporation
RAD
– –
-15,000
Closed -$2.31M
CEMP
114
DELISTED
Cempra, Inc.
CEMP
– –
-161,000
Closed -$3.9M
SHPG
115
DELISTED
Shire pic
SHPG
– –
-409,858
Closed -$26.6M
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Rhenman & Partners Asset Management held 119 positions worth $522M, down 17% from $630M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rhenman & Partners Asset Management withdrew a net $65.4M in Q4 2016, closing 11 positions and reducing 37 holdings. Its most notable exit was Shire pic, an estimated $26.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 86% a quarter earlier, followed by Financials and Technology.

Against the trend, Rhenman & Partners Asset Management opened a new position in Gilead Sciences worth $18.6M.

  • Rhenman & Partners Asset Management's largest Q4 2016 buy was Gilead Sciences: 259,894 shares worth $18.6M.
  • Rhenman & Partners Asset Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016, an estimated $6.07M increase.
  • Rhenman & Partners Asset Management's biggest Q4 2016 reduction was Celgene Corp, cutting an estimated $10.4M.
  • Rhenman & Partners Asset Management fully exited Shire pic in Q4 2016, selling an estimated $26.6M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 28% of its $522M portfolio in Q4 2016.
  • Rhenman & Partners Asset Management opened 12 new positions and closed 11 in Q4 2016.
  • Rhenman & Partners Asset Management's portfolio value fell 17% quarter-over-quarter to $522M.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.